Boston Research & Management Inc. held its stake in Stryker Corporation (NYSE:SYK) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,634 shares of the medical technology company’s stock at the close of the 2nd quarter. Boston Research & Management Inc.’s holdings in Stryker Corporation were worth $643,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in SYK. Nwam LLC purchased a new stake in Stryker Corporation during the first quarter valued at approximately $214,000. Davis Rea LTD. increased its holdings in Stryker Corporation by 1.4% during the first quarter. Davis Rea LTD. now owns 50,592 shares of the medical technology company’s stock valued at $6,682,000 after buying an additional 706 shares during the last quarter. Pillar Pacific Capital Management LLC increased its holdings in Stryker Corporation by 1.2% during the first quarter. Pillar Pacific Capital Management LLC now owns 32,340 shares of the medical technology company’s stock valued at $4,257,000 after buying an additional 375 shares during the last quarter. Signature Estate & Investment Advisors LLC increased its holdings in Stryker Corporation by 14.6% during the first quarter. Signature Estate & Investment Advisors LLC now owns 9,950 shares of the medical technology company’s stock valued at $1,310,000 after buying an additional 1,269 shares during the last quarter. Finally, Eagle Ridge Investment Management increased its holdings in Stryker Corporation by 0.6% during the first quarter. Eagle Ridge Investment Management now owns 43,174 shares of the medical technology company’s stock valued at $5,684,000 after buying an additional 245 shares during the last quarter. 74.13% of the stock is owned by institutional investors and hedge funds.

Stryker Corporation (NYSE SYK) opened at 140.89 on Monday. The firm’s 50-day moving average is $143.56 and its 200 day moving average is $138.98. Stryker Corporation has a 52-week low of $106.48 and a 52-week high of $148.84. The company has a market cap of $52.70 billion, a price-to-earnings ratio of 31.45 and a beta of 0.81.

Stryker Corporation (NYSE:SYK) last released its earnings results on Thursday, July 27th. The medical technology company reported $1.53 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.51 by $0.02. Stryker Corporation had a net margin of 14.22% and a return on equity of 24.26%. The business had revenue of $3.01 billion during the quarter, compared to analyst estimates of $2.98 billion. During the same quarter in the prior year, the firm earned $1.39 earnings per share. The company’s revenue for the quarter was up 6.1% compared to the same quarter last year. On average, equities research analysts predict that Stryker Corporation will post $6.46 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, October 31st. Stockholders of record on Friday, September 29th will be issued a dividend of $0.425 per share. This represents a $1.70 dividend on an annualized basis and a dividend yield of 1.21%. The ex-dividend date is Thursday, September 28th. Stryker Corporation’s payout ratio is 37.95%.

In other news, insider Lonny J. Carpenter sold 5,000 shares of the business’s stock in a transaction dated Friday, August 4th. The shares were sold at an average price of $146.36, for a total transaction of $731,800.00. Following the transaction, the insider now owns 88,207 shares of the company’s stock, valued at approximately $12,909,976.52. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Graham A. Mclean sold 1,124 shares of the business’s stock in a transaction dated Tuesday, August 8th. The shares were sold at an average price of $146.26, for a total transaction of $164,396.24. Following the transaction, the insider now directly owns 8,983 shares in the company, valued at approximately $1,313,853.58. The disclosure for this sale can be found here. Insiders have sold 25,429 shares of company stock valued at $3,686,927 in the last ninety days. Insiders own 7.40% of the company’s stock.

TRADEMARK VIOLATION WARNING: This report was originally posted by Daily Political and is the property of of Daily Political. If you are accessing this report on another publication, it was stolen and republished in violation of US & international copyright laws. The legal version of this report can be read at https://www.dailypolitical.com/2017/09/25/boston-research-management-inc-continues-to-hold-holdings-in-stryker-corporation-syk.html.

A number of analysts have commented on SYK shares. BMO Capital Markets reaffirmed a “hold” rating and set a $140.00 target price on shares of Stryker Corporation in a report on Tuesday, July 11th. Oppenheimer Holdings, Inc. reaffirmed a “hold” rating on shares of Stryker Corporation in a report on Monday, June 19th. Citigroup Inc. upped their target price on shares of Stryker Corporation from $114.00 to $125.00 and gave the company a “sell” rating in a report on Friday, June 9th. Cantor Fitzgerald started coverage on shares of Stryker Corporation in a report on Thursday, June 29th. They set a “neutral” rating and a $153.00 target price for the company. Finally, Morgan Stanley reaffirmed an “overweight” rating and set a $160.00 target price (up from $155.00) on shares of Stryker Corporation in a report on Monday, July 10th. Two investment analysts have rated the stock with a sell rating, nine have issued a hold rating and twelve have given a buy rating to the company. Stryker Corporation currently has a consensus rating of “Hold” and an average price target of $145.73.

About Stryker Corporation

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Institutional Ownership by Quarter for Stryker Corporation (NYSE:SYK)

Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.